HBM BioVentures

Financial Reports

Financial Reports 2010/2011

Financial Reports 2009/2010

Archive

Press Releases

Capital Market Transactions

Company Presentation

Corporate Documents

Financial reports for the 2010/2011 financial year
(1 April 2010 to 31 March 2011)

Annual Report 2010/2011
Publication on 3.6.2011

Quarterly Report December 2010
Publication on 27.1.2011

Quarterly Report September 2010
Publication on 27.10.2010

Quarterly Report June 2010
Download

News

Press Releases
»	HBM BioVentures Quarterly Report as at 30 June 2010
»	HBM BioVentures’ largest public investment – Micrus – acquired by Johnson & Johnson
»	HBM BioVentures sells USD hedging position at a profit
»	Shareholders’ meeting approves all proposals by Board of Directors by large majority; Hans Peter Hasler appointed as new Chairman of the Board of Directors; Astellas, which recently acquired OSI Pharmaceuticals, will retain HBM BioVentures shares and intensify cooperation
»	Archive

Financial Reports

»	Quarterly Report June 2010
»	Annual Report 2009/2010
»	Archive

Share Price

SIX Swiss Exchange Ticker
HBMN

Key Figures

as at 31.8.2010	CHF

NAV per share	62.58
Net assets	616 Mio.

News Registration